[Underlying Asset Performance]: HGEN.AU tracks the performance of a specific index of companies involved in the genomics and healthcare innovation sectors. The price of HGEN.AU will fluctuate based on the collective performance of these underlying companies. Positive performance from these companies will likely lead to an increase in HGEN.AU's price, while negative performance can cause a decline.

[Supply and Demand]: Like any security traded on an exchange, the price of HGEN.AU is affected by supply and demand. Higher demand will push the price up, while increased selling pressure will lower it.

[Investor Sentiment]: Overall investor sentiment towards the genomics and healthcare innovation sectors can impact HGEN.AU's price. Positive sentiment may lead to increased investment and higher prices, whereas negative sentiment can drive investors away, causing prices to fall.

[Market Conditions]: Broader market conditions, such as economic growth, interest rates, and inflation, can influence investor appetite for riskier assets like genomics and healthcare innovation companies. A strong economy and low-interest rates might encourage investment in these sectors, while a weak economy or high-interest rates could lead to a sell-off.

[Currency Fluctuations]: If the underlying companies in the index HGEN.AU tracks generate revenue or profits in foreign currencies, exchange rate fluctuations can affect their profitability and subsequently impact the ETF's price.

[Expense Ratio and Tracking Error]: HGEN.AU has an expense ratio, which represents the cost of managing the ETF. A higher expense ratio can slightly reduce returns compared to the underlying index. Additionally, tracking error, which is the difference between the ETF's performance and the index it tracks, can also affect its price relative to the index.